Raportul
Analize aprofundate ale finanțării companiilor, strategiilor de creștere și informații de piață de la cele mai inovatoare afaceri din lume
6 rapoarte și mai multe
Reprieve Cardiovascular Raises $61M in Series B
Reprieve Cardiovascular, a HealthTech company based in Milford, MA, has raised $61M in Series B at a $300M valuation led by New Enterprise Associates, Sofinnova Partners.
Reprieve Cardiovascular raises $61M Series B at $300M valuation
Reprieve Cardiovascular raises $61M in Series B at $300M valuation. Developer of therapy for acute decompensated heart failure...
Reprieve Cardiovascular Raises $61M Series B to Transform MedTech
Reprieve Cardiovascular has secured $61M Series B in funding to accelerate growth and innovation in the medtech sector. Cardiovascular device company developing personalized heart failure therapies and monitoring solutions...
New AmsterdamPharma raises $453M Series at $2B valuation
New AmsterdamPharma raises $453M in Series at $2B valuation. Developing novel cholesterol treatment drug for cardiovascular disease...
Amgen Inc Headquarters - Office Location & Address
Discover Amgen Inc's headquarters at 1 Amgen Center Dr, Thousand Oaks, CA 91320. Biotechnology company discovering, developing, and delivering innovative human therapeutics. Pioneer and world leader in biologics treating serious illnesses including oncology, cardiovascular, inflammation, and bone diseases.. Learn about the office facilities and work environment.
New AmsterdamPharma Raises $453M in Series
New AmsterdamPharma, a Biotech company based in Amsterdam, Netherlands, has raised $453M in Series at a $2B valuation led by RA Capital, RTW Investments.
Afișare 6 rapoarte • Pagina 1 • Categorie: all
Rămâneți înaintea pieței
Primiți perspective săptămânale în inbox. Fără spam, doar inteligență.